What an innovation centre means for 3D biology
In April 2021, we launched our Organoid Innovation Centre (OIC), an initiative designed to help scientists leverage the potential of 3D biology throughout the drug discovery process.
On our one-year anniversary, Drug Discovery World’s Reece Armstrong spoke to Dan O’Connor, vice president of drug discovery at Molecular Devices, about what the OIC offers to pharmaceutical companies and the advantages and barriers of 3D biology.